Insider trading

Period: 12 months Stock: NTRA Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

79 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

79 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

79 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

79 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
79 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
79 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

79 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 6×
$694.31K 3,000 at 231.44
2.1%
Planned (10b5-1)
28 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$285.19K 1,200 at 237.66
0.8%
Planned (10b5-1)
28 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$237.66K 1,000 at 237.66
0.4%
Planned (10b5-1)
28 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$220.55K 928 at 237.66
0.5%
Planned (10b5-1)
27 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$243.66K 1,013 at 240.53
0.7%
Planned (10b5-1)
27 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$213.11K 886 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$188.58K 784 at 240.53
0.4%
Planned (10b5-1)
21 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$102.93K 438 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$79.67K 339 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$68.86K 293 at 235.00
0.2%
Planned (10b5-1)
20 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
2 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$675.62K 2,951 at 228.95
2.3%
Planned (10b5-1)
12 Dec 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold at will
$1.08M 4,692 at 230.76
4.0%
Not planned
1 Dec 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$714.46K 3,000 at 238.15
2.7%
Planned (10b5-1)
4 Nov 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 2×
$4.59M 22,900 at 200.51
1.0%
Planned (10b5-1)
3 Nov 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$3.42M 17,100 at 200.00
0.7%
Planned (10b5-1)
3 Nov 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$595.81K 3,000 at 198.60
2.6%
Planned (10b5-1)
28 Oct 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$229.37K 1,198 at 191.46
1.0%
Planned (10b5-1)
28 Oct 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$202.57K 1,058 at 191.46
0.5%
Planned (10b5-1)
28 Oct 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$177.68K 928 at 191.46
0.6%
Planned (10b5-1)
27 Oct 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$193.86K 1,008 at 192.32
0.9%
Planned (10b5-1)
27 Oct 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$179.82K 935 at 192.32
0.5%
Planned (10b5-1)
27 Oct 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$150.21K 781 at 192.32
0.5%
Planned (10b5-1)
21 Oct 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$87.21K 464 at 187.95
0.2%
Planned (10b5-1)
21 Oct 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$63.72K 339 at 187.95
0.2%
Planned (10b5-1)
21 Oct 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$54.88K 292 at 187.95
0.2%
Planned (10b5-1)
20 Oct 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan
$1.90M 10,000 at 190.00
66.7%
Sold half or more
Showing 51–79 of 79. ← Newer Page 2 of 2